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Bacillus  polymyxa  was  used  to transform  ginseng  for  the  ﬁrst time.  Furthermore,  the  pharmacological
activities  of  the  conversion  products  were  evaluated.  Twelve  kinds  of  ginsenosides  of conversion  prod-
ucts  were  detected  by high  performance  liquid  chromatography  (HPLC).  The  results  showed  that  theccepted 17 March 2015




contents  of ginsenosides  Rb3,  Re,  Rd,  CK,  protopanaxadiol  were  signiﬁcantly  increased.  Moreover,  the
conversion  products  had  anti-fatigue,  immune  enhancement,  and antitumor  activities  by  the  certiﬁca-
tion  of  pharmacodynamics  experiments.  The  study  provides  a  theoretical  basis  and  reference  for  future
research  on  microbial  transformation  of ginseng.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-NDharmacological activities
. Introduction
Ginseng (Panax ginseng C.A. Meyer), an Araliaceae perennial
erb, which has main active ingredient ginsenosides, has anti-
ging, immunity, fatigue, antitumor and other pharmacological
ctivities [1–4]. Currently, the conversion methods of ginsenosides
nclude acid hydrolysis, alkaline hydrolysis, the degradation of the
nzyme, microbial conversion, and semisynthetic methods [5–10].
he microbial conversion is widely used because of its low costs
nd less by-products. A more systematic gut microbial conversion
rom ginsenosides of Rbl, Rb2 and Rc to ginsenoside CK was spec-
lated [11]. The ginsenoside -glucosidase which was successfully
solated from Paecilomyces Beini Ye (Paecilomyces Bainier)  sp.229
ith the microcrystalline cellulose as ﬁller column could convert
insenoside Rb1 into ginsenoside Rg3 [12].
In recent years, ginseng endophytes were used for the trans-
ormation of ginsenosides. Studies found that 51 bacteria were
solated from the Korean Ginseng, which at different ages could
romote the growth of the ginseng [13,14]. The ginseng endophytic
ungi was isolated and identiﬁed as well [15,16]. The endophytes
alled Bacillus polymyxa which was isolated from the fresh ginseng
as been screened by our laboratory and this strain could signiﬁ-
antly improve the ginsenosides concentration [17].
Bacillus polymyxa is a class of Gram-positive bacteria of the
enus Bacillus [18]. It is a ubiquitous bacteria existing in soil,
∗ Corresponding author. Tel.: +86 0431 8453 3171; fax: +86 0431 8453 3171.
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359-5113/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
plant epicuticular, roots, and stems [19]. It is also an important
plant biocontrol bacteria and plant growth-promoting rhizobacte-
ria, which has been widely applied in the ﬁeld of agriculture [20,21].
In addition, this species is classiﬁed by the Environmental Protec-
tion Agency as an organism that has commercial applications as
a biocontrol agent [22]. The ﬂocculants produced by Paenibacil-
lus polymyxa play an important role in sewage treatment [23].
But there are few reports about conversing ginseng with Bacillus
polymyxa and pharmacological activities of conversion products.
This is the ﬁrst study to use ginseng endophytes-Bacillus
polymyxa to transform ginseng and to research the pharmacological
activities of conversion products, which could provide a theoretical
basis and reference for the further studies of microbial transforma-
tion of ginseng.
2. Materials and methods
2.1. Materials and sample preparation
The four-year-old ginseng was collected from the Medicinal
Plant Garden of Jilin Agricultural University. Bacillus polymyxa was
from our laboratory. The 250 ml  ﬂask was ﬁlled with 100 ml  water
and 3 g ginseng powder (20–60 mesh), sterilized at 121 ◦C for
20 min  and cooled. 2 ml  of seed liquid (OD600 = 0.5) was  inoculated
to the ﬂask by pipettes under sterile conditions. Kill bacteria by
boiling water after shaking culture at 25 ◦C for 12 d. Then 1% of CMC-
Na was  added to triturate for preparing 39 mg/ml (native dose) of
fermentation broth for pharmacological experiments.
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).






















































sterile condition and calculated the immune organ index of theQ. Ji et al. / Process Bioch
Kits for liver glycogen, muscle glycogen, blood lactic acid (LD),
nd blood urea nitrogen (BUN) were purchased from Nanjing
iancheng Bioengineering Institute, kits for IL-2, TNF-, IgG1, IgE,
nd IgM were purchased from U.S.R & D company, mice anti-
ody with ﬂuorescein-labeled of CD4-PE, CD8-FITC were from U.S.
harmingen, Inc and the injection of cyclophosphamide was  pur-
hased from Shanghai Hualian Pharmaceutical Company (batch
umber: 120809). The levamisole was purchased from Ren Tang
harmaceutical Co., Ltd. Shandong.
.2. Experimental animals
ICR mice (male) weighed 20 ± 2 g were purchased from the
hangchun Biological Products. The mice were housed at a room
emperature (23 ± 1 ◦C), with 12 h light and 12 h dark cycle (lights
ere kept on from 6:00 am to 6:00 pm). Drinking water was  avail-
ble ad libitum.
.3. Determination of ginsenosides of the conversion products
.3.1. Sample preparation
1 g of ginseng powder by microbial conversion was  wrapped
ith ﬁlter paper and then was extracted within a soxhlet extractor
or 4 h at 80 ◦C. After removing the petroleum ether, the methanol
as added into the soxhlet extractor to extract continuously for
0 h at 80 ◦C. The extracted solution was collected after evapo-
ating methanol and dissolved in methanol for HPLC to a 10 ml
olumetric ﬂask. The samples were ﬁltrated through a 0.45 m
embrane ﬁlter prior to HPLC analysis. Ginsenosides of conversion
roducts and the control group which was ginseng without Bacillus
olymyxa conversion were prepared at the above conditions. There
ere three replicates for each group.
.3.2. Chromatographic conditions
The HPLC system was a Shimadzu LC-2010A instrument, with
iquid chromatography pump (LC-2010A), automatic injector and
hromatography workstation (CLASS-vP). The separation was car-
ied out on C18 column (150 mm × 4.6 mm,  5 m);  mobile phase
as of acetonitrile–water. For HPLC analysis, 20 l sample was
njected into the column and eluted at room temperature with a
onstant ﬂow rate of 1.0 ml/min. Water (solvent A) and acetonitrile
solvent B) were used. Gradient elution started with 82% solvent A
nd 18% solvent B, changed to 21% B for 40 min, then changed to
6% B for 2 min, then changed to 32% B for 4 min, changed to 33.5%
 for 20 min, changed to 38% B for 5 min, changed to 65% B for
5 min  and held for 5 min, changed to 85% B for 5 min  and held for
 min. Finally, it was changed to 18% B for 2 min and held for 1 min
o rebalance the separated column. The detection wavelength was
et to 203 nm [24].
.3.3. Calibration curves of ginsenoside standards
A stock solution of standards containing 16 ginsenosides (Rg1,
e, Rf, Rb1, Rg2, Rc, Rb2, Rb3, F1, Rd, F2, Rg3, protopanaxatriol, com-
ound K, Rh2, and protopanaxadiol were purchased from chemistry
aboratory of natural medicine in Jilin University and all stan-
ards were of biochemical-reagent grade and at least 98% pure.)
Fig. 1) in methanol was prepared and the 2, 4, 6, 10, 16, and 20 l
f the mixed-standard solutions were injected in triplicate, and
hen the calibration curves were constructed by plotting the peak
reas versus the amounts of each analyte. The concentrations of
6 ginsenosides in these samples were calculated according to the
tandard curves of 16 ginsenosides..4. Antifatigue experiments
The mice were fed for 1 week and randomly divided into
hree groups (n = 12) as follows: saline control group (0.4 ml/d),Fig. 1. HPLC chromatogram of mixed subject, the ginsenosides peak from the left
to  right order is Rg1, Re, Rf, Rb1, Rg2, Rc, Rb2, Rb3, F1, Rd, F2, Rg3, protopanaxatriol,
CK, Rh2, and protopanaxadiol.
ginseng group (15.6 mg/0.4 ml/d) and microbial conversion of gin-
seng group (15.6 mg/0.4 ml/d). 30 min after the administration, the
mice were placed in plastic cylinder (height 50 cm, 10 cm in diame-
ter), which was ﬁlled with water to a depth of 30 cm and maintained
at 30 ± 1 ◦C, then were forced to swim for 30 min  every 2 days, dried
with a towel and returned to their original cages. Animals in each
group were intragastrically administered for 28 d.
2.4.1. Loaded swimming test
After 28 days, the mice were taken from each group for the test. A
total of 60 min  after the last administration, the mice were weighed.
After that, a lead sinker (10% of the body weight) was attached to
the tail root of each mouse. When the mice were underwater within
5 s, the swimming time was  recorded immediately. Then the mice
were removed from the water and dried with a towel.
2.4.2. Determination of LD, BUN, liver glycogen, and muscle
glycogen in mice
After four weeks, some biochemical indexes were analyzed. A
total of 60 min  after the last administration, the mice were forced
to swim for 30 min and gently touched to keep the state of swim-
ming. After the mice rested for half an hour, blood was collected
through their eyeballs and serum was  prepared by centrifugation
at 4000 rpm at 4 ◦C for 15 min. The livers and quadriceps of the
mice were immediately collected and homogenized to 10% solution
with normal saline at 4 ◦C. The levels of LD, SUN, liver glycogen, and
muscle glycogen were determined according to the kits.
2.5. Immunization test
The mice were fed for one week and were randomly divided into
ﬁve groups (n = 12) as follows: saline control group, model group,
positive control group administered levamisole tablets powder
(15.6 mg/0.4 ml/d), microbial conversion group (15.6 mg/0.4 ml/d)
and ginseng group (15.6 mg/0.4 ml/d). In addition to saline con-
trol group, the mice of other groups were injected subcutaneously
with cyclophosphamide (20 mg/kg) for preparation of immuno-
deﬁcient model in the back of mice neck. After 3 consecutive
days, saline control group and modeling group were randomly
selected to determine organ index and lymphocyte counts. The
model was made successfully if there is a signiﬁcant difference
(P < 0.05) between the groups. Then the animals in each group were
intragastrically administered 28 d, 60 min  after the last administra-
tion, the experiment was carried out.
2.5.1. Immune organ index
After the last administration, the mice were fasted for 12 h,
weighed, and sacriﬁced. The spleen and thymus were weighed inspleen and the thymus according to the following formula:
Spleen index = spleen weight (mg)/body weight of mice (g)
Thymus index = weight (mg)/mouse body weight (g)

















































Transformation product and the reference of the monomer saponin concentration
(%) (N = 3).




Rg1 0.2087 ± 0.0285 0.2437 ± 0.0092
Re  0.1830 ± 0.2520 0.1541 ± 0.0050
Rf  0.0322 ± 0.0090 0.0383 ± 0.0059
Rb1 0.1970 ± 0.0209 0.2119 ± 0.0057
Rg2 0.0028 ± 0.0020 0.0056 ± 0.0002
Rc  0.1018 ± 0.0098 0.1840 ± 0.0023
Rb2 0.0759 ± 0.0160 0.0900 ± 0.0053
Rb3 0.0142 ± 0.0110 0.0027 ± 0.0106
Rd  0.1732 ± 0.0183 0.1151 ± 0.0256
F2  0.0235 ± 0.0047 0.0247 ± 0.0010
CK  0.0357 ± 0.0038 0.0150 ± 0.0057
Protopanaxadiol 0.2422 ± 0.0486 0.0276 ± 0.0223
This value represents the saponin concentration in each monomer with
mean ± standard deviation.
Fig. 2. HPLC chromatogram of conversion products, the ginsenosides peak from the
left  to right order is Rg1, Re, Rf, Rb1, Rg2, Rc, Rb2, Rb3, Rd, F2, CK, and protopanaxa-
diol.
liver glycogen were signiﬁcantly increased (P < 0.05), in which the
content of muscle glycogen and liver glycogen of the microbial
conversion group was signiﬁcantly higher than ginseng group.
Table 2
Effect of different groups on weight-loading swimming time in mice.
Experimental group Number of animals Swimming time (s)
The control group 12 461.83 ± 44.08c
Ginseng group 12 740.83 ± 50.62b018 Q. Ji et al. / Process Bioch
.5.2. Determination of CD4+, CD8+ of spleen lymphocyte subsets
The spleen was added into 10 ml  of precooled PBS solution under
terile conditions and the spleen was taken in a sterile 200 mesh
perture of the web with grinding by using a syringe needle core
nd ﬁltered and washed twice with adding cold PBS into single
ell suspension to make cell count reach the ﬁnal concentration of
 × 106 cells/ml at least. The 100 l of spleen cell suspension was
rawn into centrifuge tube then added 1 l of CD4+-FITC and 2 l
f CD8+-PE, after mixing, incubated in the dark for 30 min, washed
ith PBS and ﬁltered to add into the dedicated pipe of FACS and
nally detected the positive expression rate of CD4+ and CD8+ in T
ells by ﬂow cytometry.
.5.3. Assay of IL-2, TNF-˛, IgG1, IgE, and IgM in mice
The IL-2, TNF-, IgG1, IgE, and IgM in mice were determined by
its.
.6. Antitumor test in vitro
The logarithmic growth phase of breast cancer tumor cell MCF-7
ere seeded in 96-well plates at 1 × 104 cells/well and each well
as added 100 l and then cultured for 24 h to make the ﬁnal con-
entrations of 100, 50, 25, 12.5, 6.25, and 3.125 g/ml, respectively,
ccording to the principle of increasing concentrations of reagents.
ach concentration was set at six parallel holes. The blank control
roup was the cell culture medium without cells. The negative con-
rol group was the cell culture medium containing cells but no drug.
hey were incubated in an atmosphere of 5% CO2 in air at 37 ◦C in
 standard CO2 incubator for 2 d. After that, each hole was  added
0 l of 5 mg/ml  MTT  and continued to foster for 4 h, carefully aspi-
ating culture medium and then added 150 l of DMSO to each well.
he OD value was read in microplate reader (BIO-RAD) at 490 nm
nd calculated the rate of cell proliferation inhibition (CI) and half
nhibitory concentration (IC50).
CI (%) = (the value of the negative control group − the value of
reatment group)/the value of negative control group × 100%
.7. Statistical analysis
Data were subjected to a one-way analysis of variance (ANOVA)
ith the program SPSS 13.0. The treatments were determined
ccording to Duncan’s multiple range test at P < 0.05 in order to
dentify signiﬁcant correlates between treatments. Correlations
etween selected parameters were tested with the Pearson cor-
elation coefﬁcient. Tables were made with Microsoft excel.
. Results
.1. HPLC analysis on the conversion products
Microbial conversion group was compared with the control
roup (Table 1), ginsenosides Rb3, Re, Rd, CK, and protopanaxadiol
ere signiﬁcantly increased. In the HPLC chromatogram of trans-
ormation products (Figs. 1–3), the ratio of some ginsenosides peak
rea in the control group was less than that of the conversion group,
specially the concentrations of protopanaxadiol and ginsenoside
d.
.2. Antifatigue experiments.2.1. Loaded swimming test
The ginseng group and microbial conversion group were com-
ared with the control group (Table 2), they could signiﬁcantly
rolong the swimming time of mice (P < 0.05), in which theFig. 3. HPLC chromatogram of the control group, the ginsenosides peak from the left
to  right order is Rg1, Re, Rf, Rb1, Rg2, Rc, Rb2, Rb3, Rd, F2, CK, and protopanaxadiol.
swimming time of the microbial conversion group was  signiﬁcantly
longer than the ginseng group.
3.2.2. Determination of LD, BUN, liver glycogen, and muscle
glycogen in mice
The ginseng group and microbial conversion group compared
with the control group (Tables 3 and 4), the levels of LD, BUN
in plasma were signiﬁcantly lower (P < 0.05), in which the levels
of LD, BUN of the microbial conversion group were signiﬁcantly
lower than ginseng group. The contents of muscle glycogen andMicrobial conversion group 12 781.60 ± 34.74a
This value represents mean ± standard deviation, abc indicates signiﬁcant differences
(P  < 0.05), the same letters are not signiﬁcant but different letters have signiﬁcant
differences.
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Table  3
Effect of different groups on levels of LD, BUN in mice.
Experimental group Number of animals LD (mmol/l) BUN (mmol/l)
The control group 12 8.90 ± 0.71a 10.57 ± 0.97a
Ginseng group 12 3.91 ± 0.17b 7.49 ± 0.75b
Microbial conversion group 12 2.01 ± 0.12c 6.21 ± 0.51c
This value represents mean ± standard deviation, abc indicates signiﬁcant differences (P < 0.05), the same letters are not signiﬁcant but different letters have signiﬁcant
differences.
Table  4
Effect of different groups on contents of glycogen and muscle glycogen in mice.
Experimental group Number of animals Muscle glycogen (mg/g) Liver glycogen (mg/g)
The control group 12 1.51 ± 0.09c 3.89 ± 0.32c
Ginseng group 12 2.03 ± 0.19b 4.85 ± 0.35b
Microbial conversion group 12 2.37 ± 0.21a 6.67 ± 0.29a
This value represents mean ± standard deviation, abc indicates signiﬁcant differences (P < 0.05), the same letters are not signiﬁcant but different letters have signiﬁcant
differences.
Table  5
Effect of different groups on organ indexes in mice.
Experimental group Numbers of animals Thymus (mg/g) Spleen (mg/g)
The control group 12 2.71 ± 0.12a 5.87 ± 0.17a
model group 12 1.59 ± 0.07c 3.20 ± 0.13c
Positive control group 12 2.27 ± 0.10b 4.13 ± 0.32b
Ginseng group 12 2.04 ± 0.19 b 4.29 ± 0.34b
Microbial conversion group 12 2.76 ± 0.01a 5.98 ± 0.02a
This value represents mean ± standard deviation, abc indicates signiﬁcant differences (P < 0.05), the same letters are not signiﬁcant but different letters have signiﬁcant
differences.
Table  6
Effect of different groups on subgroup ratio of spleen cells in mice (%).
Experimental group Numbers of animals CD4+ CD8 + CD4+/CD8+
Control group 12 6.26 ± 0.06d 3.10 ± 0.35b 2.06 ± 0.05e
Model group 12 11.87 ± 0.78a 3.40 ± 0.26a 3.51 ± 0.90a
Positive control group 12 9.40 ± 2.34b 2.77 ± 0.67c 3.39 ± 0.05b
Ginseng group 12 7.50 ± 3.61c 2.50 ± 0.98c 2.94 ± 0.25c

















dhis value represents mean ± standard deviation, abcd indicates signiﬁcant differen
ifferences.
.3. Immunization experiments
.3.1. Immune organ index
After modeling, the organ index of model group was  signiﬁ-
antly reduced compared with the control group (P < 0.05) (Table 5),
he organ index of positive control group, ginseng group, and micro-
ial conversion group was signiﬁcantly increased compared with
he model group (P < 0.05), where microbial transformation group
igniﬁcantly improved than the organ index of ginseng group and
ositive control group (P < 0.05). It was also showed that, after the
reatment of levamisole, ginseng group and microbial transforma-
ion, the thymus and spleen index of immunocompromised mice
ould signiﬁcantly improve.
able 7
ffect of different groups on contents of IL-2, TNF-, IgG1, IgE, IgM in mice.
Experimental group IL-2 TNF- 
Control group 1111.23 ± 27.95c 373.26 ± 18.60a
Model group 146.58 ± 9.60d 117.50 ± 11.53c
Positive control group 1154.33 ± 32.26c 291.44 ± 13.86b
Ginseng group 1225.54 ± 34.37b 289.09 ± 33.47b
Microbial conversion group 1284.21 ± 22.02a 381.44 ± 10.16a
his value represents mean ± standard deviation, the letters indicate signiﬁcant difference
ifferences.P < 0.05), the same letters are not signiﬁcant but different letters have signiﬁcant
3.3.2. Determination of CD4+, CD8+ of spleen lymphocyte subsets
After modeling, the levels of CD4+, CD8+, and CD4+/CD8+ in the
model group signiﬁcantly increased compared with the control
group (P < 0.05) (Table 6). The levels of CD4+, CD8+, and CD4+/CD8+
of the positive control group, ginseng group and the microbial
transformation group were signiﬁcantly lower (P < 0.05). Where
CD4+, CD8+, and CD4+/CD8+ of microbial conversion group were
signiﬁcantly lower compared with ginseng group and the positive
control group (P < 0.05). It was also showed after the treatment of
levamisole, ginseng group and microbial conversion group could
signiﬁcantly affect the levels of the CD4+, CD8 + of spleen lympho-
cyte subsets and improved the immunity in mice, where the effect
of microbial conversion group was  better.
IgG1 IgE IgM
118.22 ± 11.45a 608.63 ± 51.41d 144.64 ± 5.94a
77.31 ± 1.19c 2911.24 ± 97.38a 29.25 ± 2.13c
98.14 ± 4.52b 2249.47 ± 54.74b 111.61 ± 8.22b
91.89 ± 10.45b 2227.91 ± 93.79b 107.69 ± 11.38b
109.14 ± 3.79a 1301.02 ± 21.98c 139.99 ± 7.69a




T020 Q. Ji et al. / Process Bioch.3.3. Determination of IL-2, TNF-˛, IgG1, IgE, and IgM in mice
The contents of IL-2, TNF- of the model group were signiﬁ-
antly lower (P < 0.05) compared with the control group (Table 7).
he positive control group, ginseng group and microbial conversion
Fig. 4. The effects of different groups on sy 50 (2015) 1016–1022group were signiﬁcantly increased compared with the model group
and the content of microbial transformation group was the highest.
For IgG1, the contents of IgG1 of model group were signiﬁcantly
lower (P < 0.05) compared with the control group. The positive
pleen lymphocyte subsets of mice.
Q. Ji et al. / Process Biochemistr
Table  8
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IC50 (g/ml) 102.81 259.49
his value is expressed as mean. The CI and IC50 were calculated.
ontrol group, ginseng group and microbial transformation group
ere both signiﬁcantly increased compared with the contents of
gG1 of the model group, of which the highest contents was  micro-
ial transformation group. For IgE, a signiﬁcant increase in levels
f IgE was the model group compared with the control group
P < 0.05). The positive control group, ginseng group and microbial
ransformation group were signiﬁcantly decreased compared with
he levels of IgE of the model group, of which the lowest levels
ere microbial transformation group. For IgM, the positive control
roup, ginseng group and microbial conversion were signiﬁcantly
ncreased compared with the levels of IgM of the model group. The
ighest levels were microbial transformation group. After the treat-
ent of levamisole, ginseng group and microbial transformation,
hich could signiﬁcantly affect the levels of IL-2, TNF-, IgG1, IgE,
nd IgM in immunocompromised mice and improved immunity
n mice and the effect of microbial transformation group was the
etter.
.4. Antitumor experiments in vitro
With the increase of drug concentration (Table 8), the inhibition
ate of microbial groups showed a gradual upward trend com-
ared with the ginseng group. The IC50 value of microbial groups
as signiﬁcantly lower, indicating that ginseng products by Bacillus
olymyxa conversion had better antitumor activity compared with
inseng group.
. Discussions
In the present study, HPLC method is the common determi-
ation method of ginsenosides, which can express peak area of
insenosides and determine its content. If the HPLC combined with
V, the structure and concentration of ginsenosides were known
25]. In our study, the contents of ginsenosides in conversion prod-
cts were analyzed by HPLC (Table 1). The HPLC chromatogram of
onversion products was illustrated (Figs. 1–3). Which enzyme of
acillus polymyxa can convert ginsenosides is an area that needs
urther study.
The loaded swimming test was to evaluate the index of the effect
f antifatigue and the length of the swimming time to exhaustion
ndicated the degree of fatigue [26,27]. The ginseng products by
he conversion of Bacillus polymyxa could signiﬁcantly increase the
wimming time of mice and enhance vitality (Table 2). The body
ill go on an anaerobic movement when it runs to a certain extent,
hen it will generate a lot of lactic acid from sugar decomposi-
ion and results in fatigue symptoms [28]. The ginseng products
f Bacillus polymyxa conversion could signiﬁcantly reduce the for-
ation of lactic acid in mice and reduced fatigue. When a certain
mount of sugar is broken down and then it began to consume pro-
ein to provide energy with producing urea nitrogen [29]. Studies
ave shown that the levels of blood urea nitrogen increased with
he increase of movement load. The worse the body’s resilience
as, the more obvious serum urea nitrogen increased, which werey 50 (2015) 1016–1022 1021
the products of movement load beyond a certain amount [30].
However, the conversion products could signiﬁcantly reduce the
generation of serum urea nitrogen in mice (Table 3). The contents
of glycogen directly reﬂected the state of the body’s metabolism of
glycogen, in theory, increasing the reserves of liver glycogen and
muscle glycogen reserves could provide energy for the body dur-
ing exercise and delay reduced fatigue [31]. The ginseng products
by Bacillus polymyxa conversion could reduce the consumption of
the body’s liver glycogen and muscle glycogen (Table 4). Besides,
the comparison of microbial conversion group with the control
group, could signiﬁcantly increase the swimming time of the mice
and reduce blood lactate, blood urea nitrogen, muscle glycogen,
and liver glycogen in mice. They also signiﬁcantly improved the
resistance to fatigue compared with ginseng group.
T lymphocyte cell is an important population in immune sys-
tem. Under normal circumstances, the CD4+ T cells and CD8+ T cells
of body maintain homeostasis, particularly the ratio of CD4+/CD8+
in the immune cell reﬂected the ability to regulate the immune
response [32]. T cells also secrete cytokines, such as IL-2, TNF- and
it also promotes the generation of some immunoglobulins, such as
IgG1, IgM to enhance immunity. The study was to prepare immuno-
compromised model by injecting cyclophosphamide in mice and
measure the immune organ index to afﬁrm successful modeling. By
measuring the immune organ index (Table 5), the ginseng products
by Bacillus polymyxa conversion could signiﬁcantly increase the lev-
els of the spleen and thymus index compared with ginseng group.
And the ginseng products by Bacillus polymyxa conversion could
signiﬁcantly affect the percent of spleen lymphocyte subsets CD4+,
CD8 + and the ratio of CD4+/CD8+ and improve immunity of mice
(Table 6) (Fig. 4). The ginseng products by Bacillus polymyxa con-
version could signiﬁcantly affect the levels of the IL-2, TNF-, IgG1,
IgE, and IgM levels in immunocompromised mice and the ginseng
products by Bacillus polymyxa conversion could effectively enhance
the immune capacity compared with ginseng group (Table 7).
The anti-tumor experiments in vitro have been widely used as a
model system for evaluating the antitumor of compounds [33]. As a
result, the ginseng products by Bacillus polymyxa conversion had a
certain antitumor activity compared with ginseng group. With the
increase of drug concentration of the conversion products, the inhi-
bition rate of the conversion products increased (Table 8). However,
the mechanism of antitumor of conversion products needed further
study.
5. Conclusions
This is the ﬁrst time to use ginseng endophyte-Bacillus polymyxa
to transform ginseng. The conversion products by Bacillus polymyxa
could prolong the swimming times, reduce the amount of LD and
SUN in mice after movement, reduce the consumption of glycogen
and muscle glycogen in mice after exercise. The products signiﬁ-
cantly improve the ability of antifatigue in mice. They could also
improve the index of spleen, thymus in mice, affect the ratio of
CD4+/CD8+ of spleen lymphocyte subsets in mice and the IL-2, TNF-
, IgG1, IgE, and IgM in mice have affected in varying degrees, which
showed the ginseng products by Bacillus polymyxa conversion had
the strong immunity. Meanwhile, the conversion products had a
certain antitumor activity.
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